Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.

MLA

Tan, Darren Jun Hao, et al. “Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.” Alimentary Pharmacology & Therapeutics, vol. 61, no. 2, Jan. 2025, pp. 278–85. EBSCOhost, https://doi.org/10.1111/apt.18346.

APA

Tan, D. J. H., Tamaki, N., Kim, B. K., Wijarnpreecha, K., Aboona, M. B., Faulkner, C., Kench, C., Salimi, S., Sabih, A., Lim, W. H., Danpanichkul, P., Tay, B., Teh, Y., Mok, J., Nah, B., Ng, C. H., Muthiah, M., Kulkarni, A. V., Lee, S. W., & Liu, K. (2025). Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study. Alimentary Pharmacology & Therapeutics, 61(2), 278–285. https://doi.org/10.1111/apt.18346

Chicago

Tan, Darren Jun Hao, Nobuharu Tamaki, Beom Kyung Kim, Karn Wijarnpreecha, Majd Bassam Aboona, Claire Faulkner, Charlotte Kench, et al. 2025. “Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.” Alimentary Pharmacology & Therapeutics 61 (2): 278–85. doi:10.1111/apt.18346.